Table 2. Distribution of population and PE prevalence according to Wells Score.
Population Frequency | PE Prevalence | ||||
---|---|---|---|---|---|
Wells Score | US (N = 358) N (%) | OUS (N = 702) N (%) | US | OUS | P (US vs OUS) |
0 | 201 (56.1%) | 367 (52.3%) | 1 (0.5%) | 5 (1.4%) | 0.4 |
1 | 5 (1.4%) | 13 (1.9%) | 0 | 2 (15.4%) | 1 |
1.5 | 81 (22.6%) | 131 (18.7) | 2 (2.5%) | 15 (11.5%) | 0.02 |
2.5 | 1 (0.3%) | 0 | 0 | 0 | |
3 | 47 (13.1%) | 108 (15.4%) | 3 (6.4%) | 25 (23.1%) | 0.01 |
4 | 1 (0.3%) | 4 (0.6%) | 0 | 1 (25%) | 1 |
4.5 | 20 (5.6%) | 66 (9.4%) | 3 (15%) | 20 (30.3%) | 0.25 |
5.5 | 0 | 2 (0.3%) | 0 | 1 | |
6 | 2 (0.6%) | 11 (1.6%) | 0 | 6 (54.5%) | 0.46 |
Low | 287 (80.2%) | 511 (72.8) | 3 (1%) | 22 (4.3%) | 0.01 |
Moderate | 71 (19.8%) | 191 (27.2%) | 6 (8.5%) | 53 (27.7%) | 0.0007 |
US, US patients; OUS, outside US patients
P value regards PE Prevalence